What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?

doi:10.3748/wjg.v19.i6.802

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10882)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

956

HTML

9628

Figures (1-2)

298

Sum=10882

Feb 14, 2013 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (141)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Feb 14, 2013; 19(6): 802-812
Published online Feb 14, 2013. doi: 10.3748/wjg.v19.i6.802

Full Size Figure Download Figure

Figure 2 Summary of multiple pathways underlying the protective effects of adiponectin against liver injury. MMW: Middle molecular weight; HMW: High molecular weight; AdipoR: Adiponectin receptor; UCP: Uncoupling protein; SOD1: Superoxide dismutase 1; ROS: Reactive oxygen species; PDGF-BB: Platelet-derived growth factor BB; TGF-β1: Transforming growth factor-β1; CRP: C-reactive protein; IL: Interleukin; IL-1RA: Interleukin-1-receptor antagonist; TNF-α: Tumor necrosis factor-α; HSC: Hepatic stellate cells; IFN-γ: Interferon-γ.

Citation: Finelli C, Tarantino G. What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? World J Gastroenterol 2013; 19(6): 802-812
URL: https://www.wjgnet.com/1007-9327/full/v19/i6/802.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i6.802